1.
Mihon MI, Pamfil C, Beyer R, Tomoaia R, Gherasim AR, Deac A, Zdrenghea MT, Poltorac V-I, Fodor DM, MariČ™ A, Damian LO, Rednic S. Pembrolizumab-induced fulminant triple M syndrome presenting with severe bradycardia. Med Pharm Rep [Internet]. 2025 Aug. 7 [cited 2025 Oct. 5];. Available from: https://medpharmareports.com/index.php/mpr/article/view/2834